Avita Medical, Inc. Common Stock
RCEL US05380C1027
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -38% | -46% | 113% | -6% | 4% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Mcnamara Robert |
4.50 USD |
10,000 Bought |
45,000 USD |
28/08/2025 | 28/08/2025 |
| O'toole David D CFO |
4.52 USD |
2,000 Bought |
9,040 USD |
26/08/2025 | 26/08/2025 |
| Mcnamara Robert |
5.00 USD |
10,000 Bought |
50,000 USD |
19/08/2025 | 19/08/2025 |
| O'toole David D CFO |
4.81 USD |
2,000 Bought |
9,620 USD |
12/08/2025 | 12/08/2025 |
| Mcnamara Robert |
8.30 USD |
11,000 Bought |
91,300 USD |
06/03/2025 | 06/03/2025 |
| Mcnamara Robert |
10.09 USD |
10,000 Bought |
100,900 USD |
20/02/2025 | 20/02/2025 |
| O'toole David D CFO |
9.90 USD |
1,000 Bought |
9,900 USD |
20/02/2025 | 20/02/2025 |
| O'toole David D CFO |
10.25 USD |
1,000 Bought |
10,250 USD |
19/02/2025 | 19/02/2025 |
| Crowe Suzanne |
13.15 USD |
486 Bought |
6,391 USD |
09/12/2024 | 09/12/2024 |
| O'toole David D CFO |
12.40 USD |
500 Bought |
6,200 USD |
29/11/2024 | 05/12/2024 |